Planning to make its presence dominant and stronger in Indian healthcare industry in the future, Gleneagles Global Hospitals is all set to invest Rs 200 crore for expansion.
The aim behind this investment is to expand the present facilities as quality medicare, bed strength and frontier research and so fourth with in next five to seven years.
Speaking with BusinessLine, K Ravindranath, Chairman of the Gleneagles Global Hospitals said, “We are investing to take the bed strength to 2,100 beds across our hospitals in the next two years, besides expanding to Delhi.”
Gleneagles Global Hospitals, a part of Parkway Pantai, a fully-owned subsidiary of Malaysia-based IHH Healthcare Berhad has 1,400 operational beds in its nine hospitals with the major one’s being in Hyderabad, Bengaluru, Mumbai and Chennai.
With the investment of the Rs 200 crore, the focus the healthcare industry to cross the Rs 1,000 crore turnover in fiscal 2016-17.
In year 2015, IHH Healthcare Singapore based arm of IHH entered into definitive agreements with Global Hospitals and its founder K Ravindranath besides private investors PE firm Everstone Capital, World Bank’s private investment unit IFC and broking firm Anand Rathi Financial Services among other shareholders to buy 73.4 per cent stake for Rs 1,280 crore.
“The partnership with Gleneagles will help to offer global services as they are the second-largest healthcare group in the world. The partnership will facilitate synergy between the two. We have strengths transplant surgeries, especially liver, kidney, lung, while Gleneagles has expertise in bone marrow transplant, cancer care, besides patient care, IT process and systems, ” he said.
Along with its future expansion plans, the Gleneagles Global is focusing at acquisition in Delhi. At the same time Ravindranath said thrust will also opened up the Centre of Excellence in Lung transplantion association with University of Texas, Dallas, other clinical programmes of priority for the hospital are liver and paediatric liver, Pancreas besides heart and lung transplantation.
“In each city we want to become a dominant player with 1,000 beds and the best clinical care, especially in the tertiary, quartenary care, superspeciality and multi organ transplant,” Ravindranath said.